InvestorsHub Logo
Followers 0
Posts 16
Boards Moderated 0
Alias Born 09/20/2006

Re: None

Wednesday, 09/20/2006 1:00:20 PM

Wednesday, September 20, 2006 1:00:20 PM

Post# of 6489
I posted this earlier on yahoo but for most part it got lost in the clutter... Anyone know anything????
--------------------------------------------------------------
Heres the latest release from the EMEA COMP board. Notice that an orphan designation is being granted for retinopathy of prematurity (ROP) to ROP pharma AG for mecasermin rinfabate (iPlex).

http://www.emea.eu.int/pdfs/human/comp/3...

I think I recall something about Insmed starting trails in EU for ROP. But who is "ROP pharma AB" and why would they hold the orphan designation for iPlex in EU? Not sure what's up with this does anyone know anything?

Thanks in advance,

Surf
--------------------------------------------------------------


I did some checking and also found patents in Australia filed this March related to ROP pharma and ROP diagnosis/treatment. Who is ROP pharma aligned with? and does anyone know if INSM is involved???

THanks in advance.....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News